Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Revenue

In the year 2025, Chiome Bioscience had annual revenue of 593.29M JPY, down -24.02%. Chiome Bioscience had revenue of 223.48M in the quarter ending December 31, 2025, a decrease of -37.61%.

• Revenue: 593.29M
• Revenue Growth: -24.02%
• P/S Ratio: 9.06
• Revenue / Employee: 11.19M
• Employees: 53
• Market Cap: 5.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	593.29M	-187.52M	-24.02%
Dec 31, 2024	780.81M	98.35M	14.41%
Dec 31, 2023	682.46M	51.65M	8.19%
Dec 31, 2022	630.82M	-82.12M	-11.52%
Dec 31, 2021	712.93M	232.08M	48.26%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error